Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) was the target of a large drop in short interest in November. As of November 30th, there was short interest totalling 1,017,329 shares, a drop of 9.8% from the November 15th total of 1,128,037 shares. Based on an average daily volume of 286,617 shares, the days-to-cover ratio is presently 3.5 days. Currently, 7.9% of the company’s stock are short sold.

Separately, Maxim Group reiterated a “buy” rating and issued a $1.50 price target on shares of Xtant Medical in a research note on Wednesday, November 22nd.

Shares of Xtant Medical (NYSEAMERICAN XTNT) opened at $0.59 on Tuesday. Xtant Medical has a 12 month low of $0.29 and a 12 month high of $1.21.

TRADEMARK VIOLATION NOTICE: This piece of content was originally published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/12/12/xtant-medical-holdings-inc-xtnt-short-interest-update.html.

Xtant Medical Company Profile

Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.

Receive News & Ratings for Xtant Medical Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.